Physician

Rachael Hilton Kappius, M.D.

According to 2025 Medicare claims, Rachael Kappius, M.D. (NPI: 1790147783) practices dermatology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is MOUNTAIN WEST DERMATOLOGY, PC (NPI: 1497871073; TIN: 840611546) and primary practice location at 81501-8801. Kappius is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kappius' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,011 traditional Medicare patients, billed 6,739 HCPCS/CPT codes, and received $233,327 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 692 prescription claims across 269 beneficiaries totaling $799,372 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 24 records totaling $497. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $686 to $799,372. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$117K$233K2020 Medicare payment: $58,729 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $214,353 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $224,551 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $223,851 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $233,327 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201965,468$58,729
202161123,663$214,353
20228149,243$224,551
20239245,767$223,851
20241,0116,739$233,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$400K$799K2017 Drug cost: $686 (USD; Tot_Drug_Cst)2018 Drug cost: $31,028 (USD; Tot_Drug_Cst)2019 Drug cost: $70,129 (USD; Tot_Drug_Cst)2020 Drug cost: $87,836 (USD; Tot_Drug_Cst)2021 Drug cost: $158,403 (USD; Tot_Drug_Cst)2022 Drug cost: $204,585 (USD; Tot_Drug_Cst)2023 Drug cost: $563,799 (USD; Tot_Drug_Cst)2024 Drug cost: $799,372 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171225$686
20183797$31,028
201973154$70,129
202080139$87,836
2021186429$158,403
2022204544$204,585
2023255629$563,799
2024269692$799,372

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth295338$70
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more229229$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more644875$58
17000Destruction of precancer skin growth, 1 growth572726$37
17003Destruction of precancer skin growth, 2-14 growths4242,381$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib29930$191,076
Dupixent SyringeDupilumab11308$40,730
Clobetasol PropionateClobetasol Propionate551,139$3,169
Triamcinolone AcetonideTriamcinolone Acetonide892,341$1,226
FluocinonideFluocinonide15500$1,166

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$497ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rachael Hilton Kappius, M.D.?

Tedicare shows public-source Medicare data for Rachael Hilton Kappius, M.D. (NPI 1790147783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachael Hilton Kappius, M.D. have ACO affiliation data?

Rachael Hilton Kappius, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rachael Hilton Kappius, M.D.?

Rachael Hilton Kappius, M.D. is linked to MOUNTAIN WEST DERMATOLOGY, PC (billing NPI 1497871073) in the available physician profile data.

Does Rachael Hilton Kappius, M.D. have Open Payments data?

Rachael Hilton Kappius, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.